183 related articles for article (PubMed ID: 24614921)
21. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.
Lopez-Lopez E; Gutierrez-Camino A; Astigarraga I; Navajas A; Echebarria-Barona A; Garcia-Miguel P; Garcia de Andoin N; Lobo C; Guerra-Merino I; Martin-Guerrero I; Garcia-Orad A
Pharmacogenomics; 2016 May; 17(7):731-41. PubMed ID: 27180762
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
Yang JJ; Cheng C; Yang W; Pei D; Cao X; Fan Y; Pounds SB; Neale G; Treviño LR; French D; Campana D; Downing JR; Evans WE; Pui CH; Devidas M; Bowman WP; Camitta BM; Willman CL; Davies SM; Borowitz MJ; Carroll WL; Hunger SP; Relling MV
JAMA; 2009 Jan; 301(4):393-403. PubMed ID: 19176441
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
[TBL] [Abstract][Full Text] [Related]
24. Genetic variants in microRNA biogenesis genes as novel indicators for secondary growth in Populus.
Chen B; Chen J; Du Q; Zhou D; Wang L; Xie J; Li Y; Zhang D
New Phytol; 2018 Sep; 219(4):1263-1282. PubMed ID: 29916214
[TBL] [Abstract][Full Text] [Related]
25. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia.
Gabor KM; Schermann G; Lautner-Csorba O; Rarosi F; Erdelyi DJ; Endreffy E; Berek K; Bartyik K; Bereczki C; Szalai C; Semsei AF
Pediatr Blood Cancer; 2015 Apr; 62(4):622-8. PubMed ID: 25557962
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia.
Lopez-Lopez E; Martin-Guerrero I; Ballesteros J; Piñan MA; Garcia-Miguel P; Navajas A; Garcia-Orad A
Pediatr Blood Cancer; 2011 Oct; 57(4):612-9. PubMed ID: 21387541
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects.
Deng W; Pan M; Zhu S; Chao R; Wang L
Expert Rev Hematol; 2021 Nov; 14(11):987-992. PubMed ID: 34784832
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina.
Aráoz HV; D'Aloi K; Foncuberta ME; Sanchez La Rosa CG; Alonso CN; Chertkoff L; Felice M
Leuk Lymphoma; 2015 May; 56(5):1370-8. PubMed ID: 25110820
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.
Maxwell RR; Cole PD
Curr Hematol Malig Rep; 2017 Jun; 12(3):176-186. PubMed ID: 28317081
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients.
Hareedy MS; El Desoky ES; Woillard JB; Thabet RH; Ali AM; Marquet P; Picard N
Pharmacogenomics; 2015; 16(10):1119-34. PubMed ID: 26237184
[TBL] [Abstract][Full Text] [Related]
33. Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis.
He HR; Liu P; He GH; Dong WH; Wang MY; Dong YL; Lu J
Leuk Lymphoma; 2014 Dec; 55(12):2793-800. PubMed ID: 24597986
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.
Duan R; Pak C; Jin P
Hum Mol Genet; 2007 May; 16(9):1124-31. PubMed ID: 17400653
[TBL] [Abstract][Full Text] [Related]
35. Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia.
Karpa V; Kalinderi K; Fidani L; Tragiannidis A
Hematol Rep; 2023 Nov; 15(4):634-650. PubMed ID: 37987321
[TBL] [Abstract][Full Text] [Related]
36. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
[TBL] [Abstract][Full Text] [Related]
37. MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.
Mendiola-Soto DK; Bárcenas-López DA; Pérez-Amado CJ; Cruz-Miranda GM; Mejía-Aranguré JM; Ramírez-Bello J; Hidalgo-Miranda A; Jiménez-Morales S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982511
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma.
Vagace JM; de la Maya MD; Caceres-Marzal C; Gonzalez de Murillo S; Gervasini G
Crit Rev Oncol Hematol; 2012 Nov; 84(2):274-86. PubMed ID: 22578745
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of MicroRNA92, MicroRNA638 in Acute Lymphoblastic Leukemia of Egyptian Children.
Fayed D; Donia T; El-Shanshory M; Ali EMM; Mohamed TM
Asian Pac J Cancer Prev; 2021 May; 22(5):1567-1572. PubMed ID: 34048187
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
